Search results

Found 136 pages
AUTHOR: John Pinching

Results per page

10 20 50 100

Sort by

Relevance Date

17 May 2022:

COVID-19 vaccine study focuses on young and immunosuppressed

Team at Imperial College London will expand MELODY study to include immunosuppressed young people - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/covid-19_vaccine_study_focuses_on_young_and_immunosuppressed_1448501

16 May 2022:

Positive results for AstraZeneca’s asthma therapy

PT027 is being developed through a partnership involving AstraZeneca and Avillion - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/positive_results_for_astrazenecas_asthma_therapy_1448445

18 May 2022:

EpiEndo successfully completes phase 1 study into respiratory…

Orally available EP395 has met all endpoints in safety and is now undergoing phase 2 planning - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/epiendo_successfully_completes_phase_1_study_into_respiratory_treatment_1448596

3 Jun 2020:

A whole new world

A whole new world - - Business Insights - PharmaTimes

by John Pinching|John Pinching

https://www.pharmatimes.com/business_insights/2020/a_whole_new_world

9 May 2022:

Evotenix receives patent for gene synthesis method

Vital patent for Evotenix is anticipated to enable a new generation of DNA synthesis platforms - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/evotenix_receives_patent_for_gene_synthesis_method_1448087

12 May 2022:

Superdrug launch comprehensive perimenopause screen service

High street service has been launched to support those experiencing symptoms potentially connected to the menopause - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/superdrug_launch_comprehensive_perimenopause_screen_service_1448272

16 May 2022:

Sanofi’s Sarclisa combination shows positive results in multiple…

Sarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/sanofis_sarclisa_combination_shows_positive_results_in_multiple_myeloma_patients_1448446

6 May 2022:

WHO recommends Veklury for high-risk patients

WHO have stated that Veklury recommendation is being updated following compelling new evidence of hospital reductions - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/who_recommends_veklury_for_high-risk_patients_1447951

9 May 2022:

AbbVie and Cerebras Systems partner to accelerate AI research

Link up between AbbVie and Cerebras Systems boosts AI platforms, while radically reducing energy consumption - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/abbvie_and_cerebras_systems_partner_to_accelerate_ai_research_1448088

5 May 2022:

Farxiga demonstrates success in preserved ejection fraction trial

DELIVER represents the largest ever trial to address heart failure with preserved ejection fraction - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/farxiga_demonstrates_success_in_preserved_ejection_fraction_trial_1447918